Seizure Therapy With Intravenous Levetiracetam and Lorazepam.

Trial Profile

Seizure Therapy With Intravenous Levetiracetam and Lorazepam.

Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Levetiracetam; Lorazepam
  • Indications Seizures
  • Focus Therapeutic Use
  • Acronyms STILL
  • Most Recent Events

    • 18 Apr 2012 Actual end date changed from Dec 2010 to May 2010 as reported by ClinicalTrials.gov.
    • 19 Jul 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 27 May 2008 Patient numbers amended from 350 to 100 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top